Clinical trials
Terminated Phase 2 trials in North Macedonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cellaion SA | 1 |
| G1 Therapeutics, Inc. | 1 |
| Immunic AG | 1 |
| Incyte Corporation | 1 |
| KalVista Pharmaceuticals, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute-On-Chronic Liver Failure | 1 |
| Breast Neoplasms | 1 |
| Colitis, Ulcerative | 1 |
| Cutaneous Squamous Cell Carcinoma | 1 |
| Hereditary Angioedema Types I and II | 1 |
| Neoplasm Metastasis | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.